Results 131 to 140 of about 364,439 (227)

Immunogenicity of measles-rubella vaccine administered under India's Universal Immunization Programme in the context of measles-rubella elimination goal: A longitudinal study. [PDF]

Indian J Med Res, 2023
Verma SK, Shah D, Singh A, Singh PK, Das S, Gupta P.   +5 more
europepmc   +1 more source

Buschke-Lowenstein tumor treated with intralesional measles, mumps, and rubella vaccine. [PDF]

Indian J Sex Transm Dis AIDS, 2022
Deshmukh A, Gulanikar A, Pathrikar S, Pawar SS.   +3 more
europepmc   +1 more source

Preliminary safety data from a randomised trial of early versus standard timing of administration of measles-rubella vaccine in Ugandan infants. [PDF]

Discov Med (Singap)
Businge G, Marchevsky NG, Mupere E, Kelly S, Kakai I, Kyohere M, Edielu A, Ambangira F, Kakayi B, Tusubira V, Komugisha C, Musoke P, Mujadidi YF, Bijlsma MW, Le Doare K, Voysey M.   +15 more
europepmc   +1 more source

Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine. [PDF]

Vaccine
Quach HQ, Ratishvili T, Haralambieva IH, Ovsyannikova IG, Poland GA, Kennedy RB.   +5 more
europepmc   +1 more source

Safety and Tolerance of a Novel MMR (Measles, Mumps, and Rubella) Vaccine in Indian Children: A Real-World Evidence Study. [PDF]

Cureus
Pula JR, K P, Patel RM, Mankar SV, Vinayak S, Ray S, Bhattacharjee S, Jain P, Bhatia P, Dutta T, Mahajan M.   +10 more
europepmc   +1 more source

Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. [PDF]

Public Health Pract (Oxf), 2023
Guo A, Leung J, Ayers T, Fields VS, Safi H, Waters C, Curns AT, Routh JA, Haselow DT, Marlow MA, Marin M.   +10 more
europepmc   +1 more source

Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine

, 2012
Adults 40 years of age and older have been shown to be hypo-responsive immunologically to the currently available hepatitis B virus (HBV) vaccines. Three intramuscular doses of a Toll-like receptor 9 agonist, 1018 immunostimulatory sequence (1018 ISS ...
안상훈
core  

Mumps Outbreak in Shivamogga, India (2023-2024): Age-Specific Attack Rates, Complications, and an Economic Case for Measles-Mumps-Rubella Vaccine Inclusion in the Universal Immunization Programme. [PDF]

Cureus
Gireesh S, Sakaleshpur Kumar V, S R R.
europepmc   +1 more source

Measles-rubella vaccine-associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child. [PDF]

Ther Adv Vaccines Immunother, 2022
Otiv M, Botre A, Shah P.
europepmc   +1 more source